126 related articles for article (PubMed ID: 22825802)
1. Retinal pigment epithelium tear through the fovea with maintained visual acuity of 20/20.
Ilginis T; Thomassen VH
Graefes Arch Clin Exp Ophthalmol; 2013 Apr; 251(4):1243-4. PubMed ID: 22825802
[No Abstract] [Full Text] [Related]
2. Diagnostic and therapeutic challenges.
Hatef E; Ibrahim M; Nguyen QD; Do DV; Davis MJ; Rezaei KA; Kovach JL
Retina; 2011 Jun; 31(6):1218-23. PubMed ID: 21386757
[No Abstract] [Full Text] [Related]
3. Reading the signs: Microrips as a prognostic sign for impending RPE tear development.
Clemens CR; Alten F; Eter N
Acta Ophthalmol; 2015 Nov; 93(7):e600-2. PubMed ID: 25752471
[No Abstract] [Full Text] [Related]
4. Repair mechanism of retinal pigment epithelial tears in age-related macular degeneration.
Mukai R; Sato T; Kishi S
Retina; 2015 Mar; 35(3):473-80. PubMed ID: 25207945
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of repeated anti-vascular endothelial growth factor therapy in eyes with retinal pigment epithelial tears.
Moreira CA; Arana LA; Zago RJ
Retina; 2013 Feb; 33(2):277-81. PubMed ID: 23023526
[TBL] [Abstract][Full Text] [Related]
6. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Vazquez-Alfageme C; Nicholson L; Hamilton RD; Patel PJ
Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593
[TBL] [Abstract][Full Text] [Related]
7. Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion.
Hoerster R; Muether PS; Sitnilska V; Kirchhof B; Fauser S
Retina; 2014 Sep; 34(9):1767-73. PubMed ID: 24936942
[TBL] [Abstract][Full Text] [Related]
8. RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Cho HJ; Kim HS; Yoo SG; Han JI; Lew YJ; Cho SW; Lee TG; Kim JW
Retina; 2016 Oct; 36(10):1851-9. PubMed ID: 27074658
[TBL] [Abstract][Full Text] [Related]
9. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
Introini U; Torres Gimeno A; Scotti F; Setaccioli M; Giatsidis S; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1283-92. PubMed ID: 22350060
[TBL] [Abstract][Full Text] [Related]
10. CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH RETINAL PIGMENT EPITHELIAL TEAR IMAGED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Roizenblatt M; Zett C; Saraiva VS; Maia A; Magalhães O; Moraes NSB
Retin Cases Brief Rep; 2020; 14(4):386-389. PubMed ID: 29470298
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal ranibizumab for pigment epithelium detachment with subfoveal occult choroidal neovascularization: a prospective 24-month case series.
Parodi MB; Iacono P; Papayannis A; Kontadakis SD; Cascavilla M; Pierro L; Gagliardi M; Bandello F
Am J Ophthalmol; 2013 Jan; 155(1):103-108.e2. PubMed ID: 23022164
[TBL] [Abstract][Full Text] [Related]
12. RANIBIZUMAB IN PIGMENT EPITHELIAL TEARS SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Prospective Study.
Larsen PP; Oishi A; Bedar MS; Heymer PKR; Clemens CR; König S; Gutfleisch M; Pauleikhoff D; Eter N; Wolf A; Holz FG; Krohne TU
Retina; 2019 Dec; 39(12):2369-2377. PubMed ID: 30198967
[TBL] [Abstract][Full Text] [Related]
13. Ranibizumab for the treatment of exudative age-related macular degeneration associated with retinal pigment epithelial tear.
Rouvas AA; Ladas ID; Georgalas I; Vergados I; Papakonstantinou D; Kotsolis AI
Retina; 2011 Jun; 31(6):1083-8. PubMed ID: 21427630
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography.
Inoue M; Arakawa A; Yamane S; Kadonosono K
Br J Ophthalmol; 2014 Jul; 98(7):956-60. PubMed ID: 24599418
[TBL] [Abstract][Full Text] [Related]
15. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and therapeutic challenges.
Mukkamala SK; Yannuzzi LA; Agarwal A
Retina; 2012; 32(10):2171-4. PubMed ID: 23026848
[No Abstract] [Full Text] [Related]
18. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.
Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N
Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038
[TBL] [Abstract][Full Text] [Related]
19. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration.
Kang HM; Kwon HJ; Yi JH; Lee CS; Lee SC
Am J Ophthalmol; 2014 May; 157(5):1013-21. PubMed ID: 24487050
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation of central serous chorioretinopathy following PASCAL photocoagulation.
Yang HS; Park SH
Can J Ophthalmol; 2013 Jun; 48(3):e42-3. PubMed ID: 23769790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
